CoChat

Adipose tissue‐resident regulatory T cells: phenotypic specialization, functions and therapeutic potential

Open access
Cipolletta, Daniela · 2014 · Immunology
Cited by 120

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Summary: F oxp3+ CD 4+ regulatory T (T reg) cells, recognized to be one of the most important defences of the human body against an inappropriate immune response, have recently gained attention from those outside immunology thanks to the compelling evidence for their capability to exert non‐canonical immune functions in a variety of tissues in health and disease. The recent discovery of the differences between tissue‐resident T reg cells and those derived from lymphoid organs is affecting the mindset of many investigators now questioning the broad applicability of observations originally based on peripheral blood/lymphoid organ cells. So far, the best characterized ‘T reg flavour’ comes from studies focused on their role in suppressing adipose tissue inflammation and obesity‐driven insulin resistance. Adipose tissue derived T reg cells are distinct from their counterparts in lymphoid organs based on their transcriptional profile, T‐cell receptor repertoire, and cytokine and chemokine receptor expression pattern. These cells are abundant in visceral adipose tissue of lean mice but their number is greatly reduced in insulin‐resistant animal models of obesity. Interestingly, peroxisome‐proliferator‐activated receptor γ expression by visceral adipose tissue T reg cells is crucial for their accumulation, phenotype and function in the fat and surprisingly necessary for complete restoration of insulin sensitivity in obese mice by the anti‐diabetic drug P ioglitazone. This review surveys recent findings relating to the unique phenotype and function of adipose tissue‐resident T reg cells, speculates on the nature of their dynamics in lean and obese mouse models, and analyses their potential therapeutic application in the treatment of type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/imm.12262

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

Metadata

Authors
Cipolletta, D.
Venue
Immunology
Publisher
Wiley
Published
2014-07-11
Volume
142
Issue
4
Pages
517-525
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W1996050364
Cited by
120
References
28
FWCI
10.11
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.